How does the syndromic approach impact confidence in treatment plans, as well as parent/patient satisfaction? Join Dr. Jennifer Baird as she discusses this topic with pediatrician Dr. Daniel Bruckner. This podcast was sponsored by BioFire Diagnostics This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BFR0001-3644-01 POC Podcast Episode 3

Join Dr. Jennifer Baird, Global Medical Affairs Scientist at BioFire, as she talks to pediatrician Dr. Daniel Bruckner about how to use the results of a syndromic multiplex panel and the clinical impact that it can have for pediatric patients. This podcast was sponsored by BioFire Diagnostics This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BFR0001-3643-01 POC Podcast Episode 2

In this episode, Dr. Jennifer Baird, Global Medical Affairs Scientist at BioFire, talks to Dr. Daniel Bruckner, Chair of Pediatrics at Providence Cedars-Sinai Tarzana Medical Center, about his experience using a multiplex PCR panel before and during the COVID-19 pandemic. This podcast was sponsored by BioFire Diagnostics This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BFR0001-3642-01 POC Podcast Episode 1